Hormonal Intrauterine Devices (IUDs) Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Hormonal Intrauterine Devices (IUDs) Market’s Growth Rate Evolve Over the Forecast Period to 2034?
The market size for hormonal intrauterine devices (IUDs) has seen a substantial increase in recent years. The market is set to expand from $2.61 billion in 2024 to $2.89 billion in 2025, registering a compound annual growth rate (CAGR) of 11.0%. This past growth can be credited to the introduction of safer and improved hormonal formulations, a surge in demand for long-term methods of birth control, a rise in endorsements from healthcare providers, heightened public knowledge about available contraceptive methods, and progress in medical technology and the design of devices.
The market for hormonal intrauterine devices (IUDs) is predicted to experience rapid expansion in the coming years, with growth predicted to reach $4.34 billion in 2029, reflecting a compound annual growth rate (CAGR) of 10.7%. This growth for the forecast period can be linked to increasing consciousness about contraceptive options, a growing favour for long-term reversible contraception, developments in device safety and efficacy, a rising focus on personalized healthcare, and enhanced availability through healthcare providers. Key trends for the forecast period entail advancements in device technology, increased customization of contraceptive choices, growth in patient-centric healthcare models, increasing demand for sustainable and eco-friendly products, and the creation of new contraceptive products.
How Are the key drivers Contributing to the Expansion of the Hormonal Intrauterine Devices (IUDs) Market?
The surge in unplanned pregnancies is predicted to stimulate the expansion of the hormonal intrauterine devices market in the future. Unintended pregnancies are those that were not envisaged or wanted during conception. Several factors could contribute to this occurrence including contraceptive failure, unavailability of birth control, improper use of contraceptives, or sexual violence. Inaccessibility to effective contraceptives heightens the probability of unexpected pregnancies as it hampers individuals’ dominance over their reproductive options. Hormonal IUDs are tremendously efficient in preventing pregnancy, boasting a failure rate of under 1%. They offer extensive protection (from 3 to 7 years, subject to the type) and serve as a dependable choice for those looking to avoid undesired pregnancies. For example, as reported by the Office for Health Improvement & Disparities, a UK-based governmental unit within the UK’s Department of Health and Social Care, in August 2023, from January to June 2022, England and Wales residents underwent 123,219 abortions, representing a 17% surge when compared to the corresponding timeframe in 2021. Thus, the rise in unplanned pregnancies is escalating the expansion of the hormonal intrauterine devices market.
Get Your Free Sample of the Global Hormonal Intrauterine Devices (IUDs) Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Who Are the Influential Players Reshaping the Hormonal Intrauterine Devices (IUDs) Market Landscape?
Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare
What New and Evolving Trends Are Having a Lasting Impact on the Hormonal Intrauterine Devices (IUDs) Market?
Leading organizations in the hormonal intrauterine devices market, such as levonorgestrel-releasing intrauterine systems, are focusing their efforts on the development of state-of-the-art products to provide more personalized contraceptive methods for females. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that discharge a regulated amount of levonorgestrel, an artificial progestin, into the uterus. This hormone enhances the thickness of cervical mucus and modifies the lining of the uterus to stop sperm from reaching the egg. For instance, Medicines360, a pharmaceutical firm based in the U.S. dedicated to enhancing women’s access to necessary medicines and health products, launched the U.S. Food and Drug Administration (FDA)-approved LILETTA in November 2022. LILETTA is one of the longest-lasting hormonal IUDs in the U.S., approved for up to 8 years for contraception and up to 5 years for the treatment of heavy menstrual bleeding. It boasts an efficacy rate of approximately 99% in preventing pregnancy among varied demographics. This device is designed with an ergonomic inserter for straightforward placement on the consultative day and can be removed by a healthcare professional at any time. It is available through prescription, and its cost is reduced via the 340B drug pricing program, a significant move in line with Medicines360’s goal of enhancing women’s healthcare access.
Get Instant Access to the Global Hormonal Intrauterine Devices (IUDs) Market Report with Swift Delivery!
How Are the Key Segments of the Hormonal Intrauterine Devices (IUDs) Market Driving Opportunities and Innovations?
The hormonal intrauterine devices (IUDs) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
Which Geographic Locations Are Critical to the Growth of the Hormonal Intrauterine Devices (IUDs) Market?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Hormonal Intrauterine Devices (IUDs) Market?
Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices inserted into the uterus that release progestin, a synthetic hormone. They prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to hinder implantation, and sometimes suppressing ovulation. They can also reduce menstrual bleeding and cramping and may even stop periods altogether.
Browse Through More Similar Reports By The Business Research Company:
Hearing Aid Devices And Equipment Global Market Report 2024
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Hearing Diagnostic Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
